“We see great potential for growth in the healthcare industry in Europe and Asia in the coming years,” says Dr Thilo Sandner. Ralf Sibbing adds: “Alongside newly developed medicinal products and medical devices, the growing exchange between the EU and China is transforming both markets. For us, as professional consultants and operational service providers, this provides an ideal platform for growth.”
Thilo Sandner is moving to the family-run company's senior management team from an operating management role at Diapharm. He studied business and political science in Paris and London, before earning his doctorate in innovation management. The son of the company founder Dr Stefan Sandner initially worked at Charles River Associates (formerly Cepton Strategies) in Munich and New York. Since 2017 he has been leading Diapharm’s strategic management consulting team.
(approx. 1,700 characters)